Clearance of drugs from the body Flashcards

1
Q

How are drugs cleared from the body (4)

A
  1. Some drugs are metabolised
  2. Some drugs are excreted in the faeces
  3. Some (i.e. water soluble) drugs are excreted unchanged in the urine
  4. Some drugs cleared by multiple organs (but predominantly by one)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What do we mean by Clearance? (7)

A
  1. “The volume of blood that is effectively cleared of drug in a given time period”
  2. Usually expressed in L/hr
  3. Liver and kidney responsible for most clearance
  4. Water soluble drugs excreted unchanged in urine
  5. Metabolites may be inactive
  6. Some contribution from gut wall, biliary tract and other organs
  7. Affected by blood flow, organ function and protein binding
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is the extraction ratio (4)

A
  1. Efficiency of an organ at clearing a drug
  2. ER = (Concentration entering organ - concentration leaving)/Concentration entering organ
  3. Thus, predominantly affected by blood flow, organ functionality and protein binding
  4. If ER = 1, all blood passing through organ is removed of drug
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is the elimination rate constant (4)

A
  1. Fraction of drug elimination per unit of time
  2. Usually hr-1
  3. Therefore, if K = 0.1 = one tenth (or 10%) of drug available eliminated per hour
  4. Clearance = K x Vd
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is half-life (2)

A
  1. Time it takes for amount to drug in the body to halve
  2. Half-life = ln2/k
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is first order elimination (3)

A
  1. “First Order” i.e. the rate of a process is directly proportional to the amount of drug available for the process
  2. Most drugs at therapeutic doses
  3. “Linear kinetics”
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is zero order/non-linear kinetics (7)

A
  1. After a point, rate of elimination process not proportional to amount of drug. Usually due to enzyme saturation → accumulation of excess drug
  2. Saturation point varies between patients
  3. Get higher than expected rise in plasma concentration for smaller dose increases
  4. At therapeutic doses - Half-life increases with plasma concentration
  5. In overdose, theophylline can obey zero order kinetics. Alcohol also obeys zero order kinetics
  6. Amount of drug eliminated per unit of time is constant – the proportion of drug eliminated falls as plasma concentrations rise.
  7. Therefore, effect of drug dose increases are less predictable than with drugs that have linear (first order) kinetics.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What affects hepatic clearance (6)

A
  1. Hepatic blood flow
  2. Hepatic intrinsic clearance (ability of liver to metabolise drug in absence of restricted drug delivery)
  3. Drugs with high intrinsic hepatic clearance - Metabolic rate depends on blood flow
  4. Drugs with low intrinsic hepatic clearance - Hepatic blood flow has minimal influence on metabolic rate
  5. Need to consider nature of metabolites (i.e. active vs inactive) - Patients with renal impairment will accumulate metabolites
  6. Hepatic metabolism implicated in the majority of pharmacokinetic drug-drug interactions (i.e. enzyme induction or inhibition)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the hepatic extraction ratio (8)

A
  1. Fraction of drug in blood removed by one “pass” through the liver
  2. Hepatocytes can only extract (metabolise) unbound drugs
  3. Increased hepatic blood flow will decrease extraction ratio
  4. More significant if intrinsic hepatic clearance for drug is low
  5. If intrinsic hepatic clearance is high, enzyme system can cope, and extraction ratio falls minimally
  6. Drug delivery to the cell = hepatic blood flow and protein binding
  7. Hepatocytes only have access to free (unbound) drug.
  8. Increased hepatic blood flow increases amount of drug presented to liver
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

How can first-pass metabolism be avoided (5)

A
  1. Change route of administration of the drug
  2. Glyceryl trinitrate – use sublingual tablets or spray
  3. Testosterone – use injection or transdermal gel
  4. Salbutamol – use inhaled route
  5. Remdesevir – given intravenously
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are the effects of drug interactions (5)

A
  1. If drug has high hepatic extraction ratio – even if enzyme inhibition has small effect on first pass metabolism, there’s a clinically significant changes in bioavailability
  2. E.g. if ER = 0.95, bioavailability = 0.05 → if ER reduced to 0.9 (small decrease), bioavailability increases to 0.1 (i.e. doubles)
  3. If a drug has a low extraction ratio (e.g. ER = 0.05; bioavailability = 95%):
  4. Halving ER (to 0.025) → bioavailability increases to 0.975 (97.5%)
  5. Reducing ER to a 10th of original value (to 0.005) → bioavailability increases to 0.995 (99.5%)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is renal clearance (4)

A
  1. Water soluble drugs excreted unchanged
  2. Water soluble metabolites excreted in urine
  3. Active vs inactive
  4. renal clearance = renal extraction rate (mg/min) / Drug plasma concentration (mg/L)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are the mechanisms involved in renal clearance (4)

A
  1. Filtration
  2. Active secretion
  3. Reabsorption
  4. Some drug metabolism
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

How does filtration affect drug clearance (4)

A
  1. Drugs bound to large blood constituents (e.g. plasma proteins) won’t be effectively filtered
  2. If drug is filtered freely and has no secretion or reabsorption:
  3. CLR = Glomerular Filtration Rate (GFR)
  4. Estimated creatinine clearance (eCrCl) common method for assessing renal function (GFR)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is active secretion (5)

A
  1. Carrier-mediated process
  2. Tubular transporters: organic anion transporter (OAT) and organic cation transport (ACT): each has various sub-groups
  3. Important for highly protein-bound drugs (not effectively cleared by glomerular filtration
  4. Transporters are saturable
  5. Structural analogues may compete for transport
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is active reabsorption (4)

A
  1. Many endogenous compounds (e.g. electrolytes, glucose) undergo active reabsorption (usually in proximal tubule)
  2. Accumulation may occur when filtered load exceeds system capacity

Lithium has additional consideration:

  1. If serum sodium levels low, kidneys try to re-absorb
  2. Can’t differentiate between lithium and sodium ions → potential lithium toxicity
17
Q

What is biliary clearance (4)

A
  1. Active secretion of drugs and metabolites from hepatocytes into bile
  2. Transports them to gut → excretion (faeces)
  3. Efficiency is highly variable as deconjugating enzymes and gut pH → lipophilic drug forms → reabsorption into plasma (enterohepatic re-cycling) – e.g. morphine, warfarin, metronidazole
  4. Drugs undergoing extensive enterohepatic recycling have longer durations of action
18
Q

How does breast milk affect clearance (4)

A
  1. Some drugs (and metabolites) may pass into breast milk of lactating mothers
  2. Relatively minor route, but potentially significant for the baby
  3. Breast milk has lower pH than plasma
  4. Basic drugs concentrate in breast milk via “ion trapping” – e.g. lithium (avoid), opioids
19
Q

What factors affect blood flow (3)

A
  1. Late sepsis reduces blood flow to all organs
  2. Haemorrhage
  3. Heart failure → reduced cardiac output
20
Q

What does understanding drug clearance allow (5)

A
  1. advise on drug dose adjustments
  2. Patients with hepatic impairment likely to need dose adjustments of hepatically cleared drugs
  3. Patients with renal impairment likely to need dose adjustments of both renally cleared drugs and hepatically cleared drugs that have active metabolites
  4. Need to also consider therapeutic window of drug and side effect profile
  5. May see different routes of clearance for drugs in same class